6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the Month of October 2022

000-56241

(Commission File Number)

Cresco LabsInc.

(Exact name of Registrant as specified in its charter)

400 W Erie St Suite 110

Chicago, IL 60654

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☐            Form 40-F  ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated October 24, 2022
99.2	Form 51-102F3 - Material Change Report filed October 25, 2022

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CRESCO LABS INC.
Date: October 25, 2022	By:	/s/ Charles Bachtell
		Charles Bachtell
		Chief Executive Officer

EX-99.1

Exhibit 99.1

Cresco Labs Announces Board DirectorSidney Dillard’s Resignation

CHICAGO – October 24, 2022 — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today announced that board director Sidney Dillard has tendered her resignation. Ms. Dillard has accepted a board position at a large national health insurance provider and is resigning from her Cresco Lab’s board position to avoid any potential regulatory conflicts.

“We are disappointed to see Sidney go, but we wish her the best in her new endeavor. I know she will be the same trusted advisor, independent voice, and driver of evolution in her new role,” said Charles Bachtell, Cresco Labs CEO and Co-founder. “Sidney’s depth of experience and professionalism has set the bar high, but we’ve begun searching for a new independent board member who will add to our board’s diversity of experience and knowledge.”

Ms. Sidney Dillard added, “I’d like to thank Cresco for the wonderful experience of working with an incredible team and a true industry leader focused on developing a diverse, responsible, respectable, and robust cannabis industry. I’m confident they will have continued success, and I look forward to watching from the sideline as they achieve their goals and mission. Unfortunately, today’s federal legal structure can force experienced professionals needed to shape the future of this industry to make difficult choices – I am hopeful that this will be addressed in the near future.”

Dillard’s resignation is effective immediately.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Instagram: Cresco Labs

Twitter: Cresco Labs

Media:

Jason Erkes, Cresco Labs

Chief Communications Officer

[email protected]

Investors:

Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

[email protected]

For generalCresco Labs inquiries:

312-929-0993

[email protected]

EX-99.2

Exhibit 99.2

FORM 51-102F3

MATERIAL CHANGE REPORT

Item 1.	Name and Address of Company

Cresco Labs Inc. (the “Company”)

2500 Park Place, 666 Burrard Street

Vancouver, British Columbia

V6C 2X8 Canada

Item 2.	Date of Material Change

October 24, 2022

Item 3.	News Release

A news release with respect to the material change was disseminated by the Company on October 24, 2022 through Business Wire and subsequently filed under the Company’s profile on SEDAR at www.sedar.com.

Item 4.	Summary of Material Change

On October 24, 2022, the Company announced the resignation of Sidney Dillard from its board of directors.

Item 5.1	Full Description of Material Change

On October 24, 2022, the Company announced that board director Sidney Dillard has tendered her resignation, effective immediately. Ms. Dillard has accepted a board position at a large national health insurance provider and is resigning from her board position with the Company to avoid any potential regulatory conflicts.

Item 5.2.	Disclosure of Restructuring Arrangements

Not applicable.

Item 6.	Reliance on Subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7.	Omitted Information

Not applicable.

Item 8.	Executive Officer

For further information, please contact:

John Schetz, General Counsel

Phone: (312) 929-0993

Email: [email protected]

Item 9.	Date of Report

October 25, 2022.